1. Home
  2. Pharma & Healthcare
  3. Global Prothrombin Complex Concentrate (PCC) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Prothrombin Complex Concentrate (PCC) Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Publication Month: Feb 2023 | No. of Pages: 97 Published By: Global Info Research
Single User License: US $ 3480
Corporate User License: US $ 6960

According to our (Global Info Research) latest study, the global Prothrombin Complex Concentrate (PCC) Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Prothrombin Complex Concentrate (PCC) Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prothrombin Complex Concentrate (PCC) Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prothrombin Complex Concentrate (PCC) Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prothrombin Complex Concentrate (PCC) Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Prothrombin Complex Concentrate (PCC) Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prothrombin Complex Concentrate (PCC) Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prothrombin Complex Concentrate (PCC) Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda, CSL Behring GmbH, Grifols Biologicals, Octapharma and Hualan Biological and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Prothrombin Complex Concentrate (PCC) Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others
Market segment by Application
Hemophilia B
Vitamin K Deficiency
Others
Major players covered
Takeda
CSL Behring GmbH
Grifols Biologicals
Octapharma
Hualan Biological
Meheco Xinxing Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prothrombin Complex Concentrate (PCC) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prothrombin Complex Concentrate (PCC) Drug, with price, sales, revenue and global market share of Prothrombin Complex Concentrate (PCC) Drug from 2018 to 2023.
Chapter 3, the Prothrombin Complex Concentrate (PCC) Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prothrombin Complex Concentrate (PCC) Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Prothrombin Complex Concentrate (PCC) Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prothrombin Complex Concentrate (PCC) Drug.
Chapter 14 and 15, to describe Prothrombin Complex Concentrate (PCC) Drug sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
1.1 Product Overview and Scope of Prothrombin Complex Concentrate (PCC) Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 500 IU/Vial
1.3.3 600 IU/Vial
1.3.4 1000 IU/Vial
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hemophilia B
1.4.3 Vitamin K Deficiency
1.4.4 Others
1.5 Global Prothrombin Complex Concentrate (PCC) Drug Market Size & Forecast
1.5.1 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (2018-2029)
1.5.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.1.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL Behring GmbH
2.2.1 CSL Behring GmbH Details
2.2.2 CSL Behring GmbH Major Business
2.2.3 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.2.4 CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Behring GmbH Recent Developments/Updates
2.3 Grifols Biologicals
2.3.1 Grifols Biologicals Details
2.3.2 Grifols Biologicals Major Business
2.3.3 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.3.4 Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Grifols Biologicals Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.4.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Octapharma Recent Developments/Updates
2.5 Hualan Biological
2.5.1 Hualan Biological Details
2.5.2 Hualan Biological Major Business
2.5.3 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.5.4 Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hualan Biological Recent Developments/Updates
2.6 Meheco Xinxing Pharma
2.6.1 Meheco Xinxing Pharma Details
2.6.2 Meheco Xinxing Pharma Major Business
2.6.3 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
2.6.4 Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Meheco Xinxing Pharma Recent Developments/Updates
3 Competitive Environment: Prothrombin Complex Concentrate (PCC) Drug by Manufacturer
3.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturer (2018-2023)
3.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Prothrombin Complex Concentrate (PCC) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Prothrombin Complex Concentrate (PCC) Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Prothrombin Complex Concentrate (PCC) Drug Manufacturer Market Share in 2022
3.5 Prothrombin Complex Concentrate (PCC) Drug Market: Overall Company Footprint Analysis
3.5.1 Prothrombin Complex Concentrate (PCC) Drug Market: Region Footprint
3.5.2 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
3.5.3 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
4.1.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2018-2029)
4.1.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2018-2029)
4.2 North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029)
4.3 Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029)
4.5 South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2029)
5.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2018-2029)
5.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2029)
6.2 Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2018-2029)
6.3 Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2029)
7.2 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2029)
7.3 North America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
7.3.1 North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2029)
8.2 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2029)
8.3 Europe Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
8.3.1 Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Market Size by Region
9.3.1 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2029)
10.2 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2029)
10.3 South America Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
10.3.1 South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Market Size by Country
11.3.1 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
12.2 Prothrombin Complex Concentrate (PCC) Drug Market Restraints
12.3 Prothrombin Complex Concentrate (PCC) Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Prothrombin Complex Concentrate (PCC) Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prothrombin Complex Concentrate (PCC) Drug
13.3 Prothrombin Complex Concentrate (PCC) Drug Production Process
13.4 Prothrombin Complex Concentrate (PCC) Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prothrombin Complex Concentrate (PCC) Drug Typical Distributors
14.3 Prothrombin Complex Concentrate (PCC) Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Tables and Figures

List of Tables
Table 1. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 6. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Behring GmbH Basic Information, Manufacturing Base and Competitors
Table 9. CSL Behring GmbH Major Business
Table 10. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 11. CSL Behring GmbH Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CSL Behring GmbH Recent Developments/Updates
Table 13. Grifols Biologicals Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Biologicals Major Business
Table 15. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 16. Grifols Biologicals Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Grifols Biologicals Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 21. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Octapharma Recent Developments/Updates
Table 23. Hualan Biological Basic Information, Manufacturing Base and Competitors
Table 24. Hualan Biological Major Business
Table 25. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 26. Hualan Biological Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Hualan Biological Recent Developments/Updates
Table 28. Meheco Xinxing Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Meheco Xinxing Pharma Major Business
Table 30. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 31. Meheco Xinxing Pharma Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Meheco Xinxing Pharma Recent Developments/Updates
Table 33. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Prothrombin Complex Concentrate (PCC) Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Prothrombin Complex Concentrate (PCC) Drug Production Site of Key Manufacturer
Table 38. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
Table 39. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
Table 40. Prothrombin Complex Concentrate (PCC) Drug New Market Entrants and Barriers to Market Entry
Table 41. Prothrombin Complex Concentrate (PCC) Drug Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Prothrombin Complex Concentrate (PCC) Drug Raw Material
Table 101. Key Manufacturers of Prothrombin Complex Concentrate (PCC) Drug Raw Materials
Table 102. Prothrombin Complex Concentrate (PCC) Drug Typical Distributors
Table 103. Prothrombin Complex Concentrate (PCC) Drug Typical Customers
List of Figures
Figure 1. Prothrombin Complex Concentrate (PCC) Drug Picture
Figure 2. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Type in 2022
Figure 4. 500 IU/Vial Examples
Figure 5. 600 IU/Vial Examples
Figure 6. 1000 IU/Vial Examples
Figure 7. Others Examples
Figure 8. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Application in 2022
Figure 10. Hemophilia B Examples
Figure 11. Vitamin K Deficiency Examples
Figure 12. Others Examples
Figure 13. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Prothrombin Complex Concentrate (PCC) Drug Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Prothrombin Complex Concentrate (PCC) Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Prothrombin Complex Concentrate (PCC) Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Prothrombin Complex Concentrate (PCC) Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2018-2029)
Figure 55. China Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Prothrombin Complex Concentrate (PCC) Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
Figure 76. Prothrombin Complex Concentrate (PCC) Drug Market Restraints
Figure 77. Prothrombin Complex Concentrate (PCC) Drug Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Prothrombin Complex Concentrate (PCC) Drug in 2022
Figure 80. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
Figure 81. Prothrombin Complex Concentrate (PCC) Drug Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source




Companies Mentioned
Takeda
CSL Behring GmbH
Grifols Biologicals
Octapharma
Hualan Biological
Meheco Xinxing Pharma

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets